APA

Pereira A. H. M., Cardoso A. C., Consonni S. R., Oliveira R. R., Saito A., Vaggione M. L. B., Matos-Souza J. R., Carazzolle M. F., Gonçalves A., Fernandes J. L., Ribeiro G. C. A., Lopes M. M., Molkentin J. D. & Franchini K. G. (20201002). MEF2C repressor variant deregulation leads to cell cycle re-entry and development of heart failure. : EBioMedicine.

Chicago

Pereira Ana Helena M, Cardoso Alisson C, Consonni Silvio R, Oliveira Renata R, Saito Angela, Vaggione Maria Luisa B, Matos-Souza Jose R, Carazzolle Marcelo F, Gonçalves Anderson, Fernandes Juliano L, Ribeiro Gustavo C A, Lopes Mauricio M, Molkentin Jeffery D and Franchini Kleber G. 20201002. MEF2C repressor variant deregulation leads to cell cycle re-entry and development of heart failure. : EBioMedicine.

Harvard

Pereira A. H. M., Cardoso A. C., Consonni S. R., Oliveira R. R., Saito A., Vaggione M. L. B., Matos-Souza J. R., Carazzolle M. F., Gonçalves A., Fernandes J. L., Ribeiro G. C. A., Lopes M. M., Molkentin J. D. and Franchini K. G. (20201002). MEF2C repressor variant deregulation leads to cell cycle re-entry and development of heart failure. : EBioMedicine.

MLA

Pereira Ana Helena M, Cardoso Alisson C, Consonni Silvio R, Oliveira Renata R, Saito Angela, Vaggione Maria Luisa B, Matos-Souza Jose R, Carazzolle Marcelo F, Gonçalves Anderson, Fernandes Juliano L, Ribeiro Gustavo C A, Lopes Mauricio M, Molkentin Jeffery D and Franchini Kleber G. MEF2C repressor variant deregulation leads to cell cycle re-entry and development of heart failure. : EBioMedicine. 20201002.